LYEL
Lyell Immunopharma·NASDAQ
--
--(--)
--
--(--)
LYEL fundamentals
Lyell Immunopharma (LYEL) released its earnings on Aug 12, 2025: revenue was 8.00K (YoY -38.46%), beat estimates; EPS was -2.89 (YoY +19.72%), beat estimates.
Revenue / YoY
8.00K
-38.46%
EPS / YoY
-2.89
+19.72%
Report date
Aug 12, 2025
Earnings Call
4:00 PM on Aug 12, 2025
Meeting link.EPS
Actual | -29.4 | -3.5417 | -7 | -5.5371 | -1.9 | -5.6 | -0.6 | -3.6 | -5.2 | -4 | -4.2 | -4.7861 | -3.6 | -3.4 | -8.9 | -1.86 | -2.89 |
Forecast | -7.5 | -9.4 | -5.4087 | -5.55 | -4.383 | -6.2218 | -4.55 | -5.15 | -5.25 | -4.84 | -4.6 | -4.4 | -3.95 | -3.9 | -3.4 | -3.6 | -3.52 |
Surprise | -292.00% | +62.32% | -29.42% | +0.23% | +56.65% | +9.99% | +86.81% | +30.10% | +0.95% | +17.36% | +8.70% | -8.77% | +8.86% | +12.82% | -161.76% | +48.33% | +17.90% |
Revenue
Actual | 2.63M | 2.75M | 2.82M | 553.00K | 35.74M | 2.80M | 48.39M | 65.00K | 27.00K | 25.00K | 13.00K | 3.00K | 13.00K | 34.00K | 11.00K | 7.00K | 8.00K |
Forecast | 2.31M | 2.88M | 2.64M | 776.50K | 17.87M | 1.80M | 16.13M | -17.50K | 18.00K | 6.25K | 3.25K | 1.00K | 3.25K | 0 | 0 | 0 | 4.00K |
Surprise | +13.57% | -4.26% | +6.79% | -28.78% | +100.00% | +55.56% | +200.00% | +471.43% | +50.00% | +300.00% | +300.00% | +200.00% | +300.00% | 0.00% | 0.00% | 0.00% | +100.00% |
Earnings Call
You can ask Aime
What is Lyell Immunopharma's gross profit margin?What factors drove the changes in Lyell Immunopharma's revenue and profit?What guidance did Lyell Immunopharma's management provide for the next earnings period?Did Lyell Immunopharma beat or miss consensus estimates last quarter?What is Lyell Immunopharma's latest dividend and current dividend yield?What were the key takeaways from Lyell Immunopharma’s earnings call?What were the key takeaways from Lyell Immunopharma's earnings call?What is the revenue and EPS growth rate for Lyell Immunopharma year over year?
